Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|35|4046-4058

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.35, 2014-11, pp. : 4046-4058

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoid Type 2 Receptor as a Target for Chronic - Pain

By  

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 1, 2009-01 ,pp. : 11-25

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract

By  

Current Neuropharmacology, Vol. 2, Iss. 1, 2004-01 ,pp. : 91-102

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina

By Cécyre Bruno   Thomas Sébastien   Ptito Maurice   Casanova Christian   Bouchard Jean-François  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 387, Iss. 2, 2014-02 ,pp. : 175-184

Springer Publishing Company

Access to resources Recommend Favorite

Non-Invasive Imaging of the Type 2 Cannabinoid Receptor, Focus on Positron Emission Tomography

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 15, 2010-10 ,pp. : 1527-1543

Bentham Science Publishers

Access to resources Recommend Favorite

2-Antiplasmin on Cardiovascular Diseases

By  

Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. : 841-847

Bentham Science Publishers

Access to resources Recommend Favorite